Navigation Links
Combo Treatment Eases Wheezing in Babies
Date:5/13/2009

Epinephrine, dexamethasone reduces hospitalization risk by 35%, study finds

WEDNESDAY, May 13 (HealthDay News) -- A combination of commonly used medications may ease the symptoms of bronchiolitis -- a virus-triggered condition that causes wheezing in babies.

New research suggests this treatment may reduce the risk of hospitalization by more than one-third, as well as stop wheezing sooner and get babies back to normal feeding sooner than either treatment alone or a placebo.

"Until this point, we've had no good treatment options for bronchiolitis, except for supplemental oxygen and extra fluids. In this study, we looked at two medications that have been used to treat bronchiolitis without great benefit when used separately. But, combining the two resulted in a reduction of hospitalizations," said study author Dr. Amy Plint, a pediatric emergency physician at Children's Hospital of Eastern Ontario in Ottawa, Canada.

Results of the study appear in the May 14 issue of the New England Journal of Medicine.

Bronchiolitis is a common illness in very young children. About one in three youngsters in Western countries will have at least one episode of wheezing before turning 3, according to information in an editorial in the same issue of the journal. Most of this wheezing, the editorial authors pointed out, isn't the result of asthma. Instead, it is triggered by a virus.

Plint and her colleagues included 800 infants with bronchiolitis who were between the ages of 6 weeks and 12 months. The babies were randomly assigned to one of four groups: The first group was given two treatments of nebulized epinephrine and six oral doses of the corticosteroid dexamethasone for five days; the second received nebulized epinephrine and an oral placebo; the third group received a nebulized placebo and the oral dexamethasone; and the final group was given a nebulized and oral placebo treatment.

After seven days, 17.1 percent of babies in the double-treatment group had to be hospitalized. In comparison, 23.7 percent in the epinephrine-only group had to be admitted, 25.6 percent in the dexamethasone group were hospitalized, and 26.4 percent in the placebo group were admitted to the hospital.

The group that received the combination treatment also needed less medical care, stopped wheezing sooner, and returned to normal feeding sooner than babies in the other groups.

"I think we now have good evidence of a combined treatment that appears to have benefits in reducing hospitalizations and proving treatment benefits," said Plint.

Not everyone agrees, however.

The editorial authors wrote that, "Given the small effect size of the study -- 11 infants would have to be treated to prevent one hospital admission -- it does not seem practical to apply the treatment, especially considering the potential effects of high-dose corticosteroids on brain and lung development in such young children."

However, Plint said the treatment was well-tolerated, and there's no evidence in this age group that there are any neurodevelopmental effects from a short course of steroids. And, she pointed out, steroids are often given to help the lungs mature in premature infants.

"Parents should understand when looking at different treatment modalities, a combination of medications may be more effective than either one alone. But, more studies need to be done," said Dr. Jennifer Appleyard, chief of allergy and immunology at St. John Hospital in Detroit.

Appleyard said she is concerned, however, that if this combination becomes the treatment of choice in the emergency room that children who make multiple visits over the course of a viral season might end up getting repeated high doses of steroids.

Plint said that this combination treatment should only be used for a child's first episode of wheezing.

More information

To read more about bronchiolitis, visit the U.S. National Library of Medicine.



SOURCES: Amy Plint, M.D., pediatric emergency physician, Children's Hospital of Eastern Ontario, and associate professor, pediatrics and emergency medicine, University of Ottawa, Canada; Jennifer Appleyard, M.D., chief, allergy and immunology, St. John Hospital, Detroit; May 14, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Radiation and drug combo helps boost efficacy of lung cancer treatment
2. Aerobic, Weight Training Combo Best Against Diabetes
3. New antibiotic drug combo to speed up treatment of tuberculosis
4. Drug Combo Helps Fight Marfan Syndrome
5. Drug Combo Blocks Pain Without Impairing Movement
6. Two-Drug Combo Fights Brain Tumors
7. CPR, Defibrillator Combo Boosts Cardiac Incident Survival
8. Drug Combo Boosts Multiple Myeloma Survival
9. Drug Combos Effective Against Rheumatoid Arthritis
10. Combo PET/CT Scan Helps Spot Breast Cancers Spread
11. Drug Combo With Antibiotic May Slow MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Combo Treatment Eases Wheezing in Babies
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of the most ... touted to be the next revolution in our fight against this complex disease. One ... of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While a few ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... suburbs and South Hills of Pittsburgh now have easier access to the ... only by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of ... Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over ... recently, the only option for on-premises installation of its Help System for SharePoint was ... install the system into the entire tenant. , The company recently released a ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
(Date:3/29/2017)... 2017 Neurim Pharmaceuticals ("Neurim") and ... exclusive marketing rights for Neurim,s new Rx PedPRM in ... ... sleep disorders in children with Autism Spectrum Disorders (ASD) and neurogenetic ... for children. The collaboration with Exeltis will help increase ...
(Date:3/29/2017)... Research and Markets has announced the addition of the "Global ... to their offering. ... The global patient safety and risk management software market is ... Patient safety has become a priority for almost all ... in the last decade and is currently on the verge of ...
Breaking Medicine Technology: